ELBIT SYSTEMS OF AMERICA, LLC v. THALES VISIONIX, INC.
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Moore, Wallach, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: The PTAB is entitled to weigh the credibility of expert witnesses, and attorney argument cannot be used as evidence to rebut actual admitted evidence.
Elbit sought inter partes review, challenging various claims of Thales’s patent as being obvious. In response, Thales argued that the limitation of calculating the “relative angular rate signal” was not explicitly disclosed in the prior art. Thales’s expert explained that this limitation is a two-step method and the prior art uses a three-step method. Elbit’s expert testified that two- and three-step methods are “mathematically equivalent” and have no practical difference. However, the PTAB found that Elbit’s expert testimony was unsupported and entitled to little weight because he did not address this limitation anywhere in his opinion. In contrast, the PTAB credited the testimony of Thales’s expert and concluded that Elbit had failed to meet its burden of proving the asserted claims were unpatentable.
The Federal Circuit affirmed, stating that Thales’s expert testimony constitutes substantial evidence that the prior art does not teach the “relative angular rate signal” limitation. The Federal Circuit explained that the PTAB is entitled to weigh the credibility of witnesses and declined to disturb those credibility determinations. Elbit also argued on appeal that the PTAB failed to credit the knowledge of a person of ordinary skill, but the Federal Circuit found that Elbit relied solely on attorney argument, which is not evidence and cannot rebut the admitted evidence.
This case is: ELBIT SYSTEMS OF AMERICA, LLC v. THALES VISIONIX, INC.
Written By: Ben J. Everton and Mark Rubinshtein, Ph.D.
Edited By: Paul Stewart
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…